Absci Corp (NAS:ABSI)
$ 2.99 -0.16 (-5.08%) Market Cap: 343.42 Mil Enterprise Value: 246.72 Mil PE Ratio: 0 PB Ratio: 1.79 GF Score: 55/100

Absci Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2024 / 06:30PM GMT
Release Date Price: $4.13 (-6.14%)
Dan Delfico J.P. Morgan Securities LLC;Analyst

Good morning, everybody. Welcome to the 42nd Annual J.P. Morgan Healthcare Conference. My name is Dan Delfico. I'm one of the associates on the healthcare banking team here. This morning, it's my pleasure to introduce you to the Absci team. With us today, we have Sean McClain, Founder and CEO.

(Conference Instructions)

So with that, I'm going to turn it over to Sean.

Sean McClain
Absci Corp - Chief Executive Officer, Founder, Director

Great. Thank you, Dan and J.P. Morgan, for hosting us here. As Dan said, I'm Sean McClain, the Founder and CEO of Absci. We're a data-first generative AI drug creation company. And you may recall from last J.P. Morgan, we announced some really exciting breakthroughs in generative AI for biologic design.

Being able to design an antibody from scratch with a generative AI model, being able to feed in a target of interest, and then being able to have a binder to that target.

Now, that was a big technical feat from an AI perspective. And we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot